SELLAS Life Sciences Group, Inc. (SLS)

4.245 -0.26 (-5.88%) USD  |  NASDAQ  |  Jan 23, 16:00
4.30 +0.06 (+1.30%) After-Hours: 20:00
More

SELLAS Life Sciences Group Operating Income (Quarterly YoY Growth)

Operating Income (Quarterly YoY Growth) Chart

View Operating Income (Quarterly YoY Growth) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly YoY Growth) Range, Past 5 Years

View Operating Income (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly YoY Growth) Benchmarks

View Operating Income (Quarterly YoY Growth) Benchmarks
Start Trial
GT Biopharma, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade